Par Drugs (India) Today
| PAR Stock | 294.05 12.65 4.50% |
Performance8 of 100
| Odds Of DistressLess than 1
|
Par Drugs is trading at 294.05 as of the 23rd of November 2024, a 4.50 percent increase since the beginning of the trading day. The stock's lowest day price was 281.5. Par Drugs has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Par Drugs And are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of August 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Par Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 12.3 M outstanding shares. More on Par Drugs And
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Par Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Par Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Par Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Par Drugs And (PAR) is traded on National Stock Exchange of India in India and employs 122 people. Par Drugs is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Par Drugs's market, we take the total number of its shares issued and multiply it by Par Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Par Drugs And operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 12.3 M outstanding shares.
Par Drugs generates positive cash flow from operations, but has no cash available
Check Par Drugs Probability Of Bankruptcy
Par Drugs And Risk Profiles
Although Par Drugs' alpha and beta are two of the key measurements used to evaluate Par Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.63 | |||
| Semi Deviation | 2.05 | |||
| Standard Deviation | 4.0 | |||
| Variance | 16.02 |
Par Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Par Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Par Drugs Corporate Management
Elected by the shareholders, the Par Drugs' board of directors comprises two types of representatives: Par Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Par. The board's role is to monitor Par Drugs' management team and ensure that shareholders' interests are well served. Par Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Par Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jignesh Savani | CEO Director | Profile | |
| Chintan Chauhan | Chief Officer | Profile | |
| Ghanshayambhai Savani | Whole Director | Profile | |
| Sanket Trivedi | Company Officer | Profile | |
| Falgun Savani | Chairman MD | Profile |
Other Information on Investing in Par Stock
Par Drugs financial ratios help investors to determine whether Par Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Par with respect to the benefits of owning Par Drugs security.